DDAVP IN CHILDHOOD NOCTURNAL ENURESIS
- 1 December 1978
- journal article
- research article
- Published by Wiley in Acta Paediatrica
- Vol. 67 (6), 753-755
- https://doi.org/10.1111/j.1651-2227.1978.tb16255.x
Abstract
A double-blind study of 18 children aged 6-12 yr suffering from primary nocturnal enuresis without signs of underlying organic disease is reported. 20 .mu.g of DDAVP (desamino-D-arginine vasopressin, Minirin) was given intranasally at bedtime. The effect was prompt and satisfactory in 8 children and relatively good in another 8 children. No adverse effects were noted. DDAVP is advocated for temporary use in children with nocturnal enuresis needing immediate help.Keywords
This publication has 7 references indexed in Scilit:
- EnuresisPediatric Clinics of North America, 1974
- Drugs for bed-wetting.Archives of Disease in Childhood, 1974
- Vasopressin Analogue DDAVP in Diabetes Insipidus: Clinical and Laboratory StudiesBMJ, 1973
- Rapidity of Response to the Treatment of EnuresisDevelopmental Medicine and Child Neurology, 1973
- TREATMENT OF DIABETES INSIPIDUS IN CHILDREN WITH DDAVP, A SYNTHETIC ANALOGUE OF VASOPRESSINActa Paediatrica, 1973
- Enuresis: a Descriptive Analysis and a Controlled TrialDevelopmental Medicine and Child Neurology, 1972
- Poisoning as a Complication of EnuresisDevelopmental Medicine and Child Neurology, 1972